News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Advanced Viral Research Corp. (ADVR) Shares Progress of AVR118 Phase II Cancer Cachexia Study at McGill University


4/1/2008 8:25:34 AM

YONKERS, NY--(Marketwire - April 01, 2008) - Advanced Viral Research Corp. (OTCBB: ADVR) announced today that enrollment for its Phase II efficacy study for AVR118 in cancer cachexia is progressing in line with expectations.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES